Search Results
Apr 06, 2026, 09:00 ET Bucked Up® Launches Drive Hydration and Refreshers: Two RTDs Built to Perform
Like a Million BucksRefreshers is Bucked Up's crisp, carbonated functional alternative to soda or coffee. Each sleek 12 oz can packs 100 mg caffeine, BCAAs in a 2:1:1 ratio, L-Theanine, and N-Acetyl L-Tyrosine — zero sugar, no artificial colors. Post-walk recovery, the afternoon pivot,
More news about: Bucked Up
Apr 06, 2026, 09:00 ET Abbott recebe aprovação regulatória no Brasil de serplulimabe, novo medicamento biológico para o tratamento de câncer de pulmão de pequenas células com doença extensa, oferecendo uma nova alternativa para pacientes
https://www.esmo.org/guidelines/esmo-mcbs/esmo-mcbs-for-solid-tumours/esmo-mcbs-scorecards?scorecard=470 OLIZU® 10 mg/mL (SERPLULIMABE). MS: 1.0553.0401. USO ADULTO. VIA INTRAVENOSA. INDICAÇÕES: Indicado em primeira linha para câncer do pulmão de pequenas células,
More news about: Abbott
Apr 06, 2026, 08:00 ET Alar Breaks Key Barriers in Ketamine Therapy with Positive Phase 1 Results for Long-Acting Injectable ALA-3000 for Treatment-Resistant Depression
From Day 9 to Day 36, ALA-3000 demonstrated ~3 to 6 points (150 mg) and ~2 to 4 points (250 mg) greater reduction vs. placeboRobust response rates: From Day 11 to Day 36, response rates reached ≥60% (150 mg) and 54% to 69% (250 mg) vs. 36% to 45% for placeboEncouraging remission rates:
More news about: Alar Pharmaceuticals Inc.
Apr 03, 2026, 07:00 ET Joy Organics Announces Permanent Price Reduction Across Premium USDA-Certified Organic CBD Tincture Line
delivering consistent value no matter your preferred strength. The 450mg tincture is now priced at $34.95, down from $39.95. The 900mg tincture is now $49.95, previously $59.95. The 1350mg tincture is now $69.95, reduced from $79.95. The 2250mg tincture is now available for $89.95, down from $99.95."Our
More news about: Joy Organics
Apr 02, 2026, 23:11 ET Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis
final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Nintedanib Capsules, 100 mg and 150 mg, indicated for the treatment of Idiopathic Pulmonary Fibrosis (IPF).
More news about: Cipla USA Inc.
Apr 02, 2026, 21:44 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
18.57%, to close at $5.50 per share on March 5, 2026. Then, on March 30, 2026, PepGen issued a press release announcing "clinical data from the 5 mg/kg multiple ascending dose cohort (MAD) of the ongoing Phase 2 FREEDOM2-DM1 trial in patients with myotonic dystrophy type 1 (DM1)." Although PepGen
More news about: Pomerantz LLP
Apr 02, 2026, 13:02 ET RO LAUNCHES ELI LILLY'S KWIKPEN®, OFFERING PATIENTS A MORE CONVENIENT WAY TO TAKE ZEPBOUND®
available to cash-pay patients with upfront, transparent pricing. Monthly pricing starts at $299 for the 2.5 mg starter dose and $399 for the 5 mg dose. For higher doses (7.5 mg, 10 mg, 12.5 mg, and 15 mg), eligible patients can access manufacturer discounted pricing of $449 per month when refills are completed
More news about: Ro
Apr 02, 2026, 12:03 ET La FDA aprueba Foundayo™ (orforglipron) de Lilly, la única pastilla GLP-1 para la pérdida de peso que puede tomarse a cualquier hora del día sin restricciones de comida o agua
hospital más cercano.Más informaciónFoundayo es una medicina recetada disponible en tabletas de 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, o 17.2 mg que se toman por vía oral. Llama al 1-800-545-5979 o visita
More news about: Eli Lilly and Company
Apr 02, 2026, 08:00 ET Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026
Oral semaglutide 25 mg demonstrated significantly greater mean weight loss than orforglipron 36 mg in a population-adjusted indirect treatment comparison (ITC) using data from the OASIS 4 and ATTAIN-1 clinical trials1Treatment with orforglipron 36 mg was associated with
More news about: NOVO NORDISK INC.
Apr 02, 2026, 08:00 ET Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026
Oral semaglutide 25 mg demonstrated significantly greater mean weight loss than orforglipron 36 mg in a population-adjusted indirect treatment comparison (ITC) using data from the OASIS 4 and ATTAIN-1 clinical trials1Treatment with orforglipron 36 mg was associated with
More news about: NOVO NORDISK INC.
Apr 02, 2026, 07:35 ET Lucky Energy Expands Its Beverage Line with SLUSH, Introducing Three New Flavors in a 12-oz Sleek Can
nationwide. The collection will remain a core addition to the growing Lucky Energy lineup.SLUSH delivers the performance Lucky fans expect, with 200 mg of caffeine, the brand's signature blend of five simple ingredients including maca, beta-alanine, taurine, and ginseng, plus zero sugar and zero calories.
More news about: Lucky Beverage Company
Apr 02, 2026, 07:00 ET Earendil Labs Announces First Patient Dosed in a Phase IIa Trial of a Half-life Extended Anti-TL1A Antibody (HXN-1001) in Patients with Ulcerative Colitis
more convenient treatment option for IBD patients."In the Phase I study in healthy volunteers, HXN-1001 in single doses up to 1200 mg and multiple doses of 450 mg was well tolerated with a favorable safety profile. The antibody showed a half-life of about 8 weeks when dosed in the projected therapeutic
More news about: Earendil Labs
Apr 02, 2026, 00:39 ET Toshiba ने 30-34TB SMR नियरलाइन हार्ड डिस्क ड्राइव्स की सैंपलिंग शुरू की
कॉम्पैक्ट उत्पादों के विकास के माध्यम से विकसित की गई Toshiba के स्वामित्व वाले डिज़ाइन और विश्लेषण टेक्नोलॉजियों का उपयोग करती हैं। ये पिछली पीढ़ियों (CMR MG11 और SMR MA11 सिरीज़) से बेहतर हैं क्योंकि इनमें कुल 11 डिस्क के लिए एक अतिरिक्त चुंबकीय डिस्क होती है। इसके अतिरिक्त, M12 सिरीज़ में उपयोग होने वाले रिकॉर्डिंग
More news about: Toshiba Electronic Components Taiwan Corporation
Apr 01, 2026, 23:28 ET Toshiba Mulai Mengirim Sampel Nearline Hard Disk SMR Berkapasitas 30-34 TB
teknologi desain dan analisis Toshiba yang tercapai melalui pembuatan produk yang ramping dan ringkas. Seri ini melampaui kinerja generasi sebelumnya (CMR MG11 dan SMR MA11) dengan menambahkan satu disk magnetik sehingga totalnya menjadi 11 disk. Selain itu, media perekaman yang digunakan pada
More news about: Toshiba Electronic Components Taiwan Corporation
Apr 01, 2026, 21:07 ET Mary's Medicinals Announces Its Intention to Participate in the Newly Announced Medicare and Medicaid CMS Trial Program with Its Award-Winning Cannabinoid-Based Wellness Products
Under the new BEI framework, CMS has established eligibility for products containing up to 3 mg of tetrahydrocannabinols per serving. This threshold allows for the inclusion of non-intoxicating, full-spectrum hemp-derived CBD products, a category
More news about: MM Brands Inc.
Apr 01, 2026, 19:30 ET Tanabe Pharma America Announces Finalization of RADICAVA (edaravone) Transfer to Shionogi
treatment cycle. For subsequent treatment cycles, RADICAVA ORS is taken for 10 days within a 14-day period followed by a 14-day drug-free period. Each 105 mg (5mL) dose of RADICAVA ORS should be taken in the morning after overnight fasting. Patients should not eat or drink (except water) within one hour after
More news about: Tanabe Pharma America
Apr 01, 2026, 12:16 ET Lunakai Highlights Public Health and Stress Awareness in April
Stress Less, a gummy formula that leans on the destressing power of natural ingredients, like L-Theanine (150mg), GABA (100 mg), and lemon balm (50mg). Whether it's managing pressure, meeting nutritional shortcomings, or helping establish supplemental rhythms, Lunakai's simple,
More news about: Lunakai
Apr 01, 2026, 11:30 ET FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions
hospital emergency room right away.Learn moreFoundayo is a prescription medicine available in 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, or 17.2 mg oral tablets. For more information, call 1-800-545-5979 or go to
More news about: Eli Lilly and Company
Apr 01, 2026, 08:05 ET Accord Healthcare US Reintroduces Hydrochlorothiazide Tablets, Expanding Access Across All Three Strengths
pharmaceutical company, committed to improving access to affordable medicines, today announced the re‑launch of Hydrochlorothiazide Tablets, USP in 12.5 mg, 25 mg, and 50 mg strengths.
More news about: Accord Healthcare US
Apr 01, 2026, 06:30 ET Sino Biological ProPure™ Endotoxin-Free Proteins: The "Invisible Guardian" of Biopharmaceuticals
baseline. Sino Biological's ProPure™ proteins, produced at the Center for Bioprocessing (C4B) in Texas, achieve levels as low as 0.05 EU/mg—with some products reaching 0.01 EU/mg—surpassing industry standards by more than 10-fold.How Is Endotoxin Controlled?Sino Biological ensures ultra-low
More news about: Sino Biological, Inc.
Apr 01, 2026, 02:17 ET Toshiba bắt đầu cung cấp mẫu thử ổ cứng nearline SMR dung lượng 30-34TB
kế độc quyền của Toshiba, được phát triển trong quá trình chế tạo các sản phẩm mỏng và nhỏ gọn. Dòng sản phẩm này vượt trội hơn các thế hệ trước (CMR MG11 và SMR MA11 Series) nhờ việc tích hợp thêm một đĩa từ, nâng tổng số lên 11 đĩa. Bên cạnh đó, vật liệu ghi từ sử dụng trong dòng M12 Series thay thế
More news about: Toshiba Electronic Components Taiwan Corporation
Mar 31, 2026, 16:45 ET Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
GLOW1 and GLOW2GLOW1 and GLOW2 were prospective, randomized, double-masked, sham-controlled, multicenter Phase 3 studies evaluating Zenkuda 5mg in participants with diabetic retinopathy. Both studies employed extended-interval dosing regimens with an ultimate treatment interval of every six months.
More news about: Kodiak Sciences Inc.
Mar 31, 2026, 15:00 ET Glenmark Pharmaceuticals Canada Inc. Launches Men's GLN-Minoxidil 5% w/w Topical Aerosol Foam in Canadian Retail
March 31, 2026 /PRNewswire/ -- Glenmark Pharmaceuticals Canada Inc. announced the launch of Men's GLN-Minoxidil 5% w/w (50 mg/g) Topical Aerosol Foam in Canada, expanding its OTC portfolio with a clinically proven, convenient, and affordable option for men experiencing hair loss
More news about: Glenmark Pharmaceuticals Canada Inc.
Mar 31, 2026, 11:05 ET Biostime's New A-L-G Care™ Collection of Probiotic-enriched Supplements for Babies and Kids are Formulated with Clinically Studied Probiotic Strains Trusted by Scientific Experts to Help Strengthen Immunity, Support Skin Health, and Promote Nasal & Respiratory Wellness in Babies and Kids*
Contains the clinically studied probiotic Bifidobacterium breve M-16V, a predominant strain in the gut of healthy breastfed infants, along with 750 mg per serving of FOS (Fructo-oligosaccharides) prebiotics to support the growth of beneficial gut bacteria and foster digestive wellness. * Contains no
More news about: Biostime
Mar 31, 2026, 09:11 ET Lupin Receives Tentative Approval from U.S. FDA for Sugammadex Injection
the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vial.
More news about: Lupin Pharmaceuticals, Inc.